Giant Cell Arteritis: The Experience of Two Collaborative Referral Centers and an Overview of Disease Pathogenesis and Therapeutic Advancements
Rosanna Dammacco,1 Giovanni Alessio,1 Ermete Giancipoli,2 Patrizia Leone,3 Anna Cirulli,3 Leonardo Resta,4 Angelo Vacca,3 Franco Dammacco3 1Department of Ophthalmology and Neuroscience, University of Bari “Aldo Moro”, Medical School, Bari, Italy; 2Department of Biomedical Science...
Guardado en:
Autores principales: | Dammacco R, Alessio G, Giancipoli E, Leone P, Cirulli A, Resta L, Vacca A, Dammacco F |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2020
|
Materias: | |
Acceso en línea: | https://doaj.org/article/024d19571a97492da8bdc57305dfd9e5 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Biologic Therapies for Giant Cell Arteritis
por: Harrington R, et al.
Publicado: (2021) -
Presentation and Real-World Management of Giant Cell Arteritis (Artemis Study)
por: Alfred Mahr, et al.
Publicado: (2021) -
Isquemia de extremidades inferiores secundaria a arteritis de la arteria temporal
por: Zárate B.,Cristian, et al.
Publicado: (2020) -
Functionally Heterogenous Macrophage Subsets in the Pathogenesis of Giant Cell Arteritis: Novel Targets for Disease Monitoring and Treatment
por: Idil Esen, et al.
Publicado: (2021) -
A qualitative study of patient perspectives related to glucocorticoid therapy in polymyalgia rheumatica and giant cell arteritis
por: Hoon E, et al.
Publicado: (2019)